Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4QE01
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 170 | 172 | PF00675 | 0.626 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.597 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.648 |
CLV_PCSK_KEX2_1 | 145 | 147 | PF00082 | 0.691 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.597 |
CLV_PCSK_KEX2_1 | 86 | 88 | PF00082 | 0.614 |
CLV_PCSK_PC1ET2_1 | 140 | 142 | PF00082 | 0.648 |
CLV_PCSK_PC1ET2_1 | 145 | 147 | PF00082 | 0.691 |
CLV_PCSK_PC1ET2_1 | 86 | 88 | PF00082 | 0.629 |
CLV_PCSK_PC7_1 | 141 | 147 | PF00082 | 0.599 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.646 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.602 |
DEG_SCF_FBW7_1 | 187 | 194 | PF00400 | 0.617 |
DOC_CKS1_1 | 188 | 193 | PF01111 | 0.616 |
DOC_CKS1_1 | 48 | 53 | PF01111 | 0.520 |
DOC_CYCLIN_RxL_1 | 1 | 10 | PF00134 | 0.566 |
DOC_PP4_FxxP_1 | 48 | 51 | PF00568 | 0.531 |
DOC_USP7_UBL2_3 | 145 | 149 | PF12436 | 0.581 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.636 |
DOC_WW_Pin1_4 | 187 | 192 | PF00397 | 0.622 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.534 |
DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.567 |
LIG_BRCT_BRCA1_1 | 157 | 161 | PF00533 | 0.630 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.582 |
LIG_FHA_2 | 47 | 53 | PF00498 | 0.609 |
LIG_GSK3_LRP6_1 | 191 | 196 | PF00069 | 0.506 |
LIG_LIR_Apic_2 | 47 | 51 | PF02991 | 0.538 |
LIG_LIR_Gen_1 | 55 | 62 | PF02991 | 0.559 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.560 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.585 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.468 |
LIG_SH3_1 | 33 | 39 | PF00018 | 0.482 |
LIG_SH3_2 | 195 | 200 | PF14604 | 0.608 |
LIG_SH3_2 | 36 | 41 | PF14604 | 0.541 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.555 |
LIG_SH3_3 | 33 | 39 | PF00018 | 0.502 |
LIG_SH3_5 | 152 | 156 | PF00018 | 0.582 |
MOD_CDK_SPxxK_3 | 111 | 118 | PF00069 | 0.622 |
MOD_CK1_1 | 89 | 95 | PF00069 | 0.685 |
MOD_CK2_1 | 46 | 52 | PF00069 | 0.597 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.677 |
MOD_GlcNHglycan | 76 | 79 | PF01048 | 0.580 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.598 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.663 |
MOD_GSK3_1 | 187 | 194 | PF00069 | 0.630 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.557 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.441 |
MOD_N-GLC_1 | 111 | 116 | PF02516 | 0.602 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.642 |
MOD_PIKK_1 | 156 | 162 | PF00454 | 0.629 |
MOD_PKA_1 | 86 | 92 | PF00069 | 0.579 |
MOD_PKA_2 | 86 | 92 | PF00069 | 0.518 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.626 |
MOD_ProDKin_1 | 187 | 193 | PF00069 | 0.624 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.535 |
MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.574 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.485 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.601 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC40 | Leptomonas seymouri | 64% | 100% |
A0A0S4JE60 | Bodo saltans | 31% | 100% |
A0A1X0P7T6 | Trypanosomatidae | 38% | 100% |
A0A3Q8I9X5 | Leishmania donovani | 94% | 100% |
A4H9E5 | Leishmania braziliensis | 83% | 100% |
A4HXR6 | Leishmania infantum | 93% | 100% |
D0A048 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 70% |
E9ARH8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |